These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 28714406)

  • 21. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.
    Tsukamoto H; Komohara Y; Oshiumi H
    Hum Cell; 2021 Jul; 34(4):1031-1039. PubMed ID: 33905102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving radioresponse through modification of the tumor immunological microenvironment.
    Chi KH; Wang YS; Kao SJ
    Cancer Biother Radiopharm; 2012 Feb; 27(1):6-11. PubMed ID: 22239431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Repolarisation of Tumour-Associated Macrophages.
    van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired resistance to cancer immunotherapy.
    Draghi A; Chamberlain CA; Furness A; Donia M
    Semin Immunopathol; 2019 Jan; 41(1):31-40. PubMed ID: 29968044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment.
    Rajendrakumar SK; Uthaman S; Cho CS; Park IK
    Biomacromolecules; 2018 Jun; 19(6):1869-1887. PubMed ID: 29677439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
    Musick M; Yu X
    Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy guided precision medicine in solid tumors.
    Mehrotra S; Kupani M; Kaur J; Kaur J; Pandey RK
    Adv Protein Chem Struct Biol; 2024; 140():249-292. PubMed ID: 38762271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Models for Monocytic Cells in the Tumor Microenvironment.
    Lee SWL; Adriani G; Kamm RD; Gillrie MR
    Adv Exp Med Biol; 2020; 1224():87-115. PubMed ID: 32036607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of nanotechnology in circumventing immunotolerance.
    Ma Y; Shen Y; Zhu B; Li D; Liu J
    Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK Cell Metabolism and Tumor Microenvironment.
    Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
    Front Immunol; 2019; 10():2278. PubMed ID: 31616440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance.
    Owyong M; Hosseini-Nassab N; Efe G; Honkala A; van den Bijgaart RJE; Plaks V; Smith BR
    Drug Resist Updat; 2017 Nov; 33-35():23-35. PubMed ID: 29145972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joining Forces: Improving Clinical Response to Cellular Immunotherapies with Small-Molecule Inhibitors.
    Sinha D; Smith C; Khanna R
    Trends Mol Med; 2021 Jan; 27(1):75-90. PubMed ID: 33011081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophages: Key orchestrators of a tumor microenvironment defined by therapeutic resistance.
    Long KB; Collier AI; Beatty GL
    Mol Immunol; 2019 Jun; 110():3-12. PubMed ID: 29273393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages: A promising target for a cancer immunotherapeutic strategy.
    Zhang SY; Song XY; Li Y; Ye LL; Zhou Q; Yang WB
    Pharmacol Res; 2020 Nov; 161():105111. PubMed ID: 33065284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
    Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
    Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Opportunities and Challenges in Cancer Immunotherapy.
    Whiteside TL; Demaria S; Rodriguez-Ruiz ME; Zarour HM; Melero I
    Clin Cancer Res; 2016 Apr; 22(8):1845-55. PubMed ID: 27084738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes Function in Tumor Immune Microenvironment.
    Huang Y; Liu K; Li Q; Yao Y; Wang Y
    Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.